Physician profile
Athanasios Antoniadis
NPI 1730286485
$1,168.66
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $145 · 2021: $449 · 2022: $168 · 2023: $33.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $33.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $344.22 | 2019-2022 | |
| Lupin INC. | $142.86 | 2019 | |
| Allergan, INC. | $105.95 | 2019-2020 | |
| Exeltis, USA INC. | $100.86 | 2021-2022 | |
| Pfizer INC. | $97.58 | 2019-2021 | |
| Hologic Sales and Service, LLC | $71.60 | 2022-2023 | Coolseal Generator |
| Agile Therapeutics, INC. | $59.69 | 2021 | |
| Mayne Pharma Commercial LLC | $47.76 | 2021 | |
| Myovant Sciences INC. | $43.99 | 2021-2022 | |
| Avion Pharmaceuticals | $38.01 | 2019-2022 | |
| Vertical Pharmaceuticals, LLC | $34.28 | 2019 | |
| Coopersurgical, INC. | $31.32 | 2022 | |
| Amgen INC. | $21.10 | 2019 | |
| Aspira Women'S Health INC | $16.94 | 2021 | |
| Therapeuticsmd, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athanasios Antoniadis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.